about
Effects of Whole-Body Vibration Therapy in Patients with Fibromyalgia: A Systematic Literature ReviewEfficacy of EMG- and EEG-Biofeedback in Fibromyalgia Syndrome: A Meta-Analysis and a Systematic Review of Randomized Controlled TrialsSevere forms of fibromyalgia with acute exacerbation of pain: costs, comorbidities, and length of stay in inpatient care.Role and rationale for the use of milnacipran in the management of fibromyalgiaImpact of potential pregabalin or duloxetine drug-drug interactions on health care costs and utilization among Medicare members with fibromyalgia.Effect of low-level laser therapy on pain, quality of life and sleep in patients with fibromyalgia: study protocol for a double-blinded randomized controlled trial.Duloxetine for the treatment of fibromyalgia.Improving the recognition and diagnosis of fibromyalgia.Postural control deficits in people with fibromyalgia: a pilot study.The Comparative Burden of Chronic Widespread Pain and Fibromyalgia in the United States.Traditional Chinese medicine diagnoses in a sample of women with fibromyalgiaMilnacipran: a selective serotonin and norepinephrine dual reuptake inhibitor for the management of fibromyalgiaEffect of milnacipran on body weight in patients with fibromyalgiaSystemic lupus erythematosus and primary fibromyalgia can be distinguished by testing for cell-bound complement activation productsResults of switching to milnacipran in fibromyalgia patients with an inadequate response to duloxetine: a phase IV pilot studyObjectively measured sedentary time and physical activity in women with fibromyalgia: a cross-sectional studyMilnacipran combined with pregabalin in fibromyalgia: a randomized, open-label study evaluating the safety and efficacy of adding milnacipran in patients with incomplete response to pregabalinEvaluating increased resource use in fibromyalgia using electronic health records.Effects of milnacipran on neurocognition, pain, and fatigue in fibromyalgia: a 13-week, randomized, placebo-controlled, crossover trial.Continuing efficacy of milnacipran following long-term treatment in fibromyalgia: a randomized trial.Effects of treatment of myofascial trigger points on the pain of fibromyalgia.Health care costs in patients with fibromyalgia on pregabalin vs. duloxetine.An insight into the gastrointestinal component of fibromyalgia: clinical manifestations and potential underlying mechanisms.Clinical Characteristics of Fibromyalgia in a Chronic Pain Population.The management of fibromyalgia from a psychosomatic perspective: an overview.United States Physical Therapists' Knowledge About Joint Hypermobility Syndrome Compared with Fibromyalgia and Rheumatoid Arthritis.Anxiety, depression and alexithymia in fibromyalgia: are there any differences according to age?Financial conflicts of interest and their association with outcome and quality of fibromyalgia drug therapy randomized controlled trials.Diagnostic uncertainty and epistemologic humility.Effect of intravenous lidocaine combined with amitriptyline on pain intensity, clinical manifestations and the concentrations of IL-1, IL-6 and IL-8 in patients with fibromyalgia: A randomized double-blind study.A simple screening test to recognize fibromyalgia in primary care patients with chronic pain.Attachment styles, pain intensity and emotional variables in women with fibromyalgia.Meta-analysis of cognitive performance in fibromyalgia.Effects of treatment of peripheral pain generators in fibromyalgia patients.Individuals with fibromyalgia and depression: findings from a nationally representative Canadian survey.Characterizing classes of fibromyalgia within the continuum of central sensitization syndrome
P2860
Q26782459-DA569E17-F72E-4676-8312-2F5987524B89Q26995435-BEA000D0-54F1-4F13-839B-A8392FBAE54CQ33766468-DEFF52D3-93B2-4CDC-AE57-4A2AFC85FB2CQ33881505-E5EF4D53-0C03-473F-8EAE-D00ADBD94A13Q34379796-9971CF49-CE87-4FC0-8B1F-8C1449FA9B9BQ34484775-5AD6A208-BC32-498A-A1B4-EC5DE05FA035Q34663934-6546DB82-0F02-4ADC-9901-7E1E4F470642Q34887973-092A5B9A-2317-4E12-9B80-09429B5B057EQ35617687-9006D8E3-2A33-4E6D-A03E-FD469511A06AQ35633313-1A2775AC-AC77-4567-8F18-6417524B198FQ35848916-80AE062E-576F-430E-BCAE-7601CA3468A6Q36059500-D6F2F83E-8ED7-4005-8C5A-6FC54FDEB281Q36344060-FF4497C4-1100-4E65-B39B-E64BC81003FCQ36559699-73DFB9D7-149B-4830-B65C-4C31CB128694Q36813454-3E9E1760-D311-49C9-9CB5-8B82FC75E035Q36939304-AF164C6E-DB00-461E-821D-363E37422775Q36999721-AC6A9AAE-5767-4B4E-BD08-A56C145DC91DQ37426947-19BEB911-5104-4451-8950-CEAD9241DF4FQ37688599-727046DA-B7A6-4CCE-B178-5205D6471CFEQ37690346-7C89778B-3D78-47BA-9085-35E22395505DQ37871923-842C669C-17CD-40A5-A6D6-527E703E93A4Q37880281-939EB90C-FB09-4DD1-8CC1-D38570673927Q38239602-E8B137D7-0519-40C8-AFA6-31905F8809FDQ38831991-640DAB38-0B0B-47D6-A1EC-4330C9BD1A6AQ39417649-FA5AD002-E266-4AB0-94E6-87B31D28452AQ41693484-36CBA660-FF6A-4B71-A15E-ABF519573DF5Q44204539-8134D0BE-6B2C-46F8-96F4-016DEBD7E450Q46354967-FD70E67A-046A-45ED-82FF-9AD1374CBB27Q46553970-144FCAD0-62E7-42D9-AF6A-EEBE741073AAQ47372143-A1662D64-2FA8-4F08-B0A6-C394529935ECQ47600628-DFB25E62-4315-4125-9395-716AA72EB40CQ47774452-E6AF6C24-19FC-4B5D-A104-ABBCEED6090BQ48126235-E179DA5D-302E-4AB6-B5D9-F1AC15FEF615Q48321564-9DC1A80A-614F-495F-B0D5-CC9BBC034F35Q48931464-F188E9A5-A781-4CFF-9FFE-59911C805230Q58698673-73CC9D14-3392-48C8-8986-7AF4311C875B
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Clinical manifestations and diagnosis of fibromyalgia.
@ast
Clinical manifestations and diagnosis of fibromyalgia.
@en
type
label
Clinical manifestations and diagnosis of fibromyalgia.
@ast
Clinical manifestations and diagnosis of fibromyalgia.
@en
prefLabel
Clinical manifestations and diagnosis of fibromyalgia.
@ast
Clinical manifestations and diagnosis of fibromyalgia.
@en
P1476
Clinical manifestations and diagnosis of fibromyalgia.
@en
P304
P356
10.1016/J.RDC.2009.05.009
P577
2009-05-01T00:00:00Z